Published January 2, 2021 | Version v1
Journal article

Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients

Contributors

Others:

Description

The present study was performed to examine relationships between systemic exposure of capecitabine metabolites (5-FU, 5'-DFCR and 5'-DFUR) and toxicity or clinical response in patients with metastatic breast cancer.

Abstract

International audience

Additional details

Identifiers

URL
https://hal.science/hal-05029832
URN
urn:oai:HAL:hal-05029832v1

Origin repository

Origin repository
UNICA